PORTFOLIO NEWS Carmot Therapeutics Closes $160 Million Series D Financing to Advance Clinical Pipeline of Novel Incretin Receptor Modulators July 26, 2022 Read More » Circle Pharma Appoints Paul Park MBA as CBO July 26, 2022 Read More » Kallyope and Brightseed Enter Collaboration to Identify and Validate Novel Plant-Based Bioactives July 21, 2022 Read More » Nurix Therapeutics Announces $40 Million Registered Direct Offering July 8, 2022 Read More » Nurix Therapeutics Announces $55 Million Registered Direct Offering July 7, 2022 Read More » Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update July 7, 2022 Read More » Kallyope, Pioneers in Drug Discovery via the Gut-Brain Axis, Advances Discovery and Development Teams With New Appointments July 6, 2022 Read More » Tenaya Therapeutics Publishes Preclinical Data in Science Translational Medicine Detailing Discovery of HDAC6 Inhibitor for Treatment of Heart Failure July 6, 2022 Read More » NGM Bio Appoints Siobhan Nolan Mangini to President and Chief Financial Officer June 30, 2022 Read More » Nurix Therapeutics Announces Clearance of Investigational New Drug Application For NX-1607 Supporting Plans to Expand Enrollment to U.S. Clinical Sites June 30, 2022 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Next »
Carmot Therapeutics Closes $160 Million Series D Financing to Advance Clinical Pipeline of Novel Incretin Receptor Modulators July 26, 2022 Read More »
Kallyope and Brightseed Enter Collaboration to Identify and Validate Novel Plant-Based Bioactives July 21, 2022 Read More »
Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update July 7, 2022 Read More »
Kallyope, Pioneers in Drug Discovery via the Gut-Brain Axis, Advances Discovery and Development Teams With New Appointments July 6, 2022 Read More »
Tenaya Therapeutics Publishes Preclinical Data in Science Translational Medicine Detailing Discovery of HDAC6 Inhibitor for Treatment of Heart Failure July 6, 2022 Read More »
NGM Bio Appoints Siobhan Nolan Mangini to President and Chief Financial Officer June 30, 2022 Read More »
Nurix Therapeutics Announces Clearance of Investigational New Drug Application For NX-1607 Supporting Plans to Expand Enrollment to U.S. Clinical Sites June 30, 2022 Read More »
